Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies
The development of multidrug resistance (MDR) and subsequent relapse on therapy is a widespread problem in breast cancer, but our understanding of the underlying molecular mechanisms is incomplete. Numerous studies have aimed to establish the role of drug transporter pumps in MDR and to link their e...
Saved in:
| Main Authors: | N. S. Wind, I. Holen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.4061/2011/967419 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
News in the studies of multidrug resistance of breast cancer cells
by: A. A. Stavrovskaya, et al.
Published: (2015-06-01) -
Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal
by: Ashirwad Jadhav, et al.
Published: (2025-06-01) -
The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer
by: T. A. Bogush, et al.
Published: (2014-07-01) -
Combination Therapy for Overcoming Multidrug Resistance in Breast Cancer Through Hedgehog Signaling Pathway Regulation
by: Yujie Liu, et al.
Published: (2025-04-01) -
Gradient phenomenon of multidrug resistance gene expression in breast cancer during neoadjuvant chemotherapy is related to disease progression
by: N. V. Litviakov
Published: (2016-02-01)